Talphera, Inc. SEC filings TLPH

Talphera, Inc. has 962 filings in SEC EDGAR's recent list, going back to Feb 19, 2008. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.

Talphera, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 12, 2026 —
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 23, 2026 Jun 22, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 22, 2026
EFFECT Filing Apr 1, 2026 —
424B7 Form 424b7 Apr 1, 2026 —
CORRESP Letter to the SEC Mar 30, 2026 —
UPLOAD Letter from the SEC Mar 30, 2026 —
S-3 Shelf registration Mar 25, 2026 —
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 23, 2026 Mar 23, 2026
8-K Current report
Unregistered share sale
Mar 16, 2026 Mar 13, 2026
8-K Current report
Listing notice
Mar 13, 2026 Mar 11, 2026
424B7 Form 424b7 Dec 2, 2025 —
EFFECT Filing Dec 1, 2025 —
CORRESP Letter to the SEC Nov 25, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
S-3 Shelf registration Oct 28, 2025 —
S-8 Employee stock plan registration Oct 28, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Oct 24, 2025 Oct 23, 2025
8-K Current report
Unregistered share sale, Other events
Oct 22, 2025 Oct 20, 2025
8-K Current report
Officer or director change
Oct 16, 2025 Oct 14, 2025
EFFECT Filing Sep 29, 2025 —
424B7 Form 424b7 Sep 29, 2025 —
CORRESP Letter to the SEC Sep 25, 2025 —
UPLOAD Letter from the SEC Sep 25, 2025 —
ARS Annual report to shareholders Sep 24, 2025 Dec 31, 2024
S-3 Shelf registration Sep 22, 2025 —
D Filing Sep 15, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Sep 10, 2025 Sep 7, 2025
DEFA14A Additional proxy material Sep 9, 2025 —
DEF 14A Proxy statement Sep 9, 2025 Oct 23, 2025
PRE 14A Preliminary proxy statement Aug 29, 2025 Oct 23, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Listing notice
Jun 5, 2025 May 30, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
EFFECT Filing May 12, 2025 —
424B7 Form 424b7 May 12, 2025 —
CORRESP Letter to the SEC May 9, 2025 —
UPLOAD Letter from the SEC May 8, 2025 —
S-3 Shelf registration May 2, 2025 —
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
D Filing Apr 17, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Apr 2, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Listing notice
Dec 11, 2024 Dec 6, 2024
8-K Current report
Listing notice
Nov 29, 2024 Nov 27, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Material agreement
Oct 1, 2024 Sep 30, 2024
S-8 Employee stock plan registration Aug 14, 2024 —
8-K Current report
Results of operations, Officer or director change
Aug 14, 2024 Aug 12, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2024 Jun 24, 2024
S-8 Employee stock plan registration May 20, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 24, 2024
8-K Current report
Other events
Apr 19, 2024 Apr 19, 2024
10-K Annual report Mar 6, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 6, 2024 Mar 6, 2024
8-K Current report
Officer or director change, Other events
Mar 1, 2024 Feb 26, 2024
EFFECT Filing Feb 13, 2024 —
424B7 Form 424b7 Feb 13, 2024 —
CORRESP Letter to the SEC Feb 9, 2024 —
UPLOAD Letter from the SEC Feb 9, 2024 —
S-3 Shelf registration Feb 6, 2024 —
D Filing Jan 29, 2024 —
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Officer or director change, Regulation FD disclosure
Jan 22, 2024 Jan 17, 2024
8-K Current report
Material agreement
Jan 18, 2024 Jan 12, 2024
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
EFFECT Filing Nov 30, 2023 —
CORRESP Letter to the SEC Nov 29, 2023 —
UPLOAD Letter from the SEC Nov 29, 2023 —
S-3 Shelf registration Nov 22, 2023 —
S-8 Employee stock plan registration Nov 22, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Listing notice
Oct 20, 2023 Oct 18, 2023
8-K Current report
Officer or director change, Shareholder vote results
Oct 10, 2023 Oct 10, 2023
DEFA14A Additional proxy material Oct 5, 2023 —
8-K Current report
Auditor change, Other events
Oct 5, 2023 Oct 2, 2023
8-K Current report
Other events
Sep 22, 2023 Sep 22, 2023
DEFA14A Additional proxy material Aug 28, 2023 —
DEF 14A Proxy statement Aug 28, 2023 Oct 10, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
EFFECT Filing Aug 9, 2023 —
424B7 Form 424b7 Aug 9, 2023 —
CORRESP Letter to the SEC Aug 7, 2023 —
UPLOAD Letter from the SEC Aug 7, 2023 —
S-3 Shelf registration Aug 2, 2023 —
8-K Current report
Other events
Aug 1, 2023 Dec 31, 2022
D Filing Jul 28, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Jul 21, 2023 Jul 17, 2023
8-K Current report
Other events
Jun 15, 2023 Jun 15, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 10, 2023 May 10, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
8-K Current report
Listing notice
Apr 28, 2023 Apr 26, 2023
UPLOAD Letter from the SEC Apr 11, 2023 —
CORRESP Letter to the SEC Apr 11, 2023 —
8-K Current report
Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
Apr 7, 2023 Apr 3, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
UPLOAD Letter from the SEC Mar 30, 2023 —
8-K Current report
Results of operations, Restatement
Mar 30, 2023 Mar 30, 2023
8-K Current report
Material agreement, Agreement ended
Mar 16, 2023 Mar 12, 2023
8-K Current report
Other events
Dec 29, 2022 Dec 27, 2022
424B5 Prospectus supplement Dec 28, 2022 —
8-K Current report
Agreement ended
Dec 5, 2022 Nov 29, 2022
EFFECT Filing Nov 22, 2022 —
424B7 Form 424b7 Nov 22, 2022 —
CORRESP Letter to the SEC Nov 21, 2022 —
UPLOAD Letter from the SEC Nov 21, 2022 —
S-3 Shelf registration Nov 15, 2022 —
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Bylaw or fiscal year change
Oct 25, 2022 Oct 25, 2022
8-K Current report
Shareholder vote results
Sep 23, 2022 Sep 23, 2022
D Filing Aug 17, 2022 —
DEFA14A Additional proxy material Aug 12, 2022 —
DEF 14A Proxy statement Aug 12, 2022 Sep 23, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Aug 12, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Aug 4, 2022 Aug 3, 2022
PRE 14A Preliminary proxy statement Aug 3, 2022 Aug 3, 2022
8-K Current report
Listing notice
Jul 28, 2022 Jul 27, 2022
8-K/A Amended current report
Shareholder vote results
Jul 26, 2022 Jul 15, 2022
8-K/A Amended current report
Shareholder vote results
Jul 25, 2022 Jul 15, 2022
DEFA14A Additional proxy material Jul 18, 2022 —
8-K Current report
Shareholder vote results
Jul 15, 2022 Jul 15, 2022
DEFA14A Additional proxy material Jun 3, 2022 —
DEF 14A Proxy statement Jun 3, 2022 Jul 15, 2022
8-K Current report
Agreement ended, Listing notice
Jun 2, 2022 May 31, 2022
PRE 14A Preliminary proxy statement May 24, 2022 Jul 15, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Listing notice
May 9, 2022 May 6, 2022
EFFECT Filing May 3, 2022 —
424B7 Form 424b7 May 3, 2022 —
S-3/A Form s-3/a Apr 22, 2022 —
10-K/A Amended annual report Apr 20, 2022 Dec 31, 2021
S-3 Shelf registration Apr 15, 2022 —
8-K Current report
Other events
Mar 31, 2022 Mar 28, 2022
10-K Annual report Mar 10, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 10, 2022 Mar 10, 2022
8-K Current report
Officer or director change
Mar 1, 2022 Feb 23, 2022
8-K Current report
Officer or director change
Feb 14, 2022 Feb 9, 2022
D Filing Jan 24, 2022 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
Jan 12, 2022 Jan 7, 2022
8-K Current report
Listing notice
Dec 3, 2021 Dec 2, 2021
8-K Current report
Officer or director change
Nov 23, 2021 Nov 20, 2021
424B5 Prospectus supplement Nov 15, 2021 —
8-K Current report
Other events
Nov 15, 2021 Nov 15, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations, Other events
Nov 15, 2021 Nov 15, 2021
S-8 Employee stock plan registration Aug 18, 2021 —
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 16, 2021 Aug 16, 2021
8-K Current report
Auditor change
Jul 29, 2021 Jul 29, 2021
8-K Current report
Material agreement
Jul 14, 2021 Jul 14, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2021 Jun 17, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
8-K Current report
Material agreement
Apr 27, 2021 Apr 21, 2021
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 17, 2021
8-K Current report
Officer or director change
Mar 31, 2021 Mar 30, 2021
8-K Current report
Material agreement, Agreement ended, New debt
Mar 30, 2021 Mar 26, 2021
10-K Annual report Mar 15, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 15, 2021 Mar 15, 2021
8-K Current report
Officer or director change
Mar 9, 2021 Mar 3, 2021
8-K Current report
Other events
Feb 16, 2021 Feb 11, 2021
8-K Current report
Material agreement
Jan 21, 2021 Jan 19, 2021
424B5 Prospectus supplement Jan 21, 2021 —
424B5 Prospectus supplement Jan 19, 2021 —
8-K Current report
Results of operations, Other events
Jan 14, 2021 Jan 14, 2021
424B5 Prospectus supplement Dec 10, 2020 —
8-K Current report
Other events
Dec 10, 2020 Dec 9, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Material agreement, Agreement ended
Oct 6, 2020 Oct 1, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
424B5 Prospectus supplement Jul 23, 2020 —
8-K Current report
Material agreement, Results of operations, Other events
Jul 23, 2020 Jul 17, 2020
EFFECT Filing Jul 8, 2020 —
CORRESP Letter to the SEC Jul 7, 2020 —
CORRESP Letter to the SEC Jul 6, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TLPH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Mateo, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1427925
Former names
ACELRX PHARMACEUTICALS INC (until Dec 14, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.